ArticleArthritis research & therapy2018

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.

Suzanne Cole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.